[Federal Register Volume 60, Number 69 (Tuesday, April 11, 1995)]
[Notices]
[Pages 18410-18411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-8860]



-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION
[Dkt. C-3565]


IVAX Corp.; Prohibited Trade Practices, and Affirmative 
Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

-----------------------------------------------------------------------

SUMMARY: In settlement of alleged violations of federal law prohibiting 
unfair acts and practices and unfair methods of competition, this 
consent order permits, among other things, IVAX, a Florida corporation, 
to acquire Zenith Laboratories, except for Zenith's rights to market or 
sell extended release generic verapamil under Zenith's exclusive 
distribution agreement with G.D. Searle & Co. Respondent is also 
[[Page 18411]] required, for ten years, to obtain Commission approval 
before acquiring any stock in any entity that manufactures, or is an 
exclusive distributor for another manufacturer of, extended release 
generic verapamil in the United States.

DATES: Complaint and Order issued March 27, 1995.\1\

    \1\Copies of the Complaint and the Decision and Order are 
available from the Commission's Public Reference Branch, H-130, 6th 
Street & Pennsylvania Avenue, NW., Washington, DC 20580.
---------------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT:
Melissa Heydenreich, FTC/S-2224, Washington, DC 20580, (202) 326-2543.

SUPPLEMENTARY INFORMATION: On Thursday, January 5, 1995, there was 
published in the Federal Register, 60 FR 1782, a proposed consent 
agreement with analysis In the Matter of IVAX Corporation, for the 
purpose of soliciting public comment. Interested parties were given 
sixty (60) days in which to submit comments, suggestions or objections 
regarding the proposed form of the order.
    No comments having been received, the Commission has ordered the 
issuance of the complaint in the form contemplated by the agreement, 
made its jurisdictional findings and entered an order to cease and 
desist, as set forth in the proposed consent agreement, in disposition 
of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 
Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; 15 U.S.C. 
45, 18)
Donald S. Clark,
Secretary.
[FR Doc. 95-8860 Filed 4-10-95; 8:45 am]
BILLING CODE 6750-01-M